These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33539184)

  • 21. [The French health care funding system for research and innovation in oncology].
    Wiernik H; Katz G; Coulonjou H; Salagnac A; Kletz F; Thariat J
    Bull Cancer; 2018 Jun; 105(6):581-595. PubMed ID: 29747854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anatomy of medical research: US and international comparisons.
    Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
    JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea.
    Park J; Chung E
    World Dev; 2021 Jan; 137():105198. PubMed ID: 32982017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breaking the chain: Governmental frugal innovation in Kerala to combat the COVID-19 pandemic.
    Sarkar S
    Gov Inf Q; 2021 Jan; 38(1):101549. PubMed ID: 33318722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivering High-Quality, Equitable Care in India: An Ethically-Resilient Framework for Healthcare Innovation After COVID-19.
    Ozair A; Singh KK
    Front Public Health; 2021; 9():640598. PubMed ID: 33681137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Leadership in Public Sector Innovation: A Systematic Review and Meta-Analysis of the Management of COVID-19 in Asian Countries.
    Sazzad F; Rajan VP; Demircioglu MA
    Front Public Health; 2021; 9():743748. PubMed ID: 34976914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current barriers, challenges and opportunities for the development of effective STI vaccines: point of view of vaccine producers, biotech companies and funding agencies.
    Dodet B
    Vaccine; 2014 Mar; 32(14):1624-9. PubMed ID: 23994377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crowd-sourcing delivery system innovation: A public-private solution.
    Agrawal S; Chen C; Tanio CP
    Healthc (Amst); 2015 Mar; 3(1):2-4. PubMed ID: 26179583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerating global innovation to address antibacterial resistance: introducing CARB-X.
    Outterson K; Rex JH; Jinks T; Jackson P; Hallinan J; Karp S; Hung DT; Franceschi F; Merkeley T; Houchens C; Dixon DM; Kurilla MG; Aurigemma R; Larsen J
    Nat Rev Drug Discov; 2016 Sep; 15(9):589-590. PubMed ID: 27469032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. India's crusade against COVID-19.
    Madkaikar M; Gupta N; Yadav RM; Bargir UA
    Nat Immunol; 2021 Mar; 22(3):258-259. PubMed ID: 33627877
    [No Abstract]   [Full Text] [Related]  

  • 31. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea.
    Lee S
    Front Public Health; 2020; 8():563525. PubMed ID: 33282810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Vaccines: A Primer for Clinicians.
    Romero JR; Bernstein HH
    Pediatr Ann; 2020 Dec; 49(12):e532-e536. PubMed ID: 33290571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator.
    Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Priority setting during the COVID-19 pandemic: going beyond vaccines.
    Williams I; Essue B; Nouvet E; Sandman L; Razavi SD; Noorulhuda M; Goold S; Danis M; Biemba G; Abelson J; Kapiriri L
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33461979
    [No Abstract]   [Full Text] [Related]  

  • 39. Repairing the broken market for antibiotic innovation.
    Outterson K; Powers JH; Daniel GW; McClellan MB
    Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic sustainability, a look at the philosophy behind one of Spain's flagship cardiovascular institutes, the CNIC.
    Guzik TJ; Fuster V
    Cardiovasc Res; 2021 Sep; 117(11):e151-e155. PubMed ID: 34585720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.